Humacyte
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $753 | $301 | $517 | $7,228 |
Gross Profit | 493 | -1,772 | -1,462 | 3,614 |
EBITDA | -13,033 | -33,253 | 43,971 | -16,624 |
EBIT | -14,898 | -35,113 | 42,139 | -18,432 |
Net Income | -17,510 | -37,658 | 39,139 | -20,940 |
Net Change In Cash | 753 | 301 | 517 | 7,228 |
Free Cash Flow | -23,953 | -26,981 | -28,829 | -26,640 |
Cash | 19,488 | 38,032 | 62,847 | 44,937 |
Basic Shares | 158,313 | 155,437 | 131,759 | 118,479 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,565 | $1,263 |
Gross Profit | -7,190 | -76,550 | -6,690 | -60,078 |
EBITDA | -132,234 | -96,458 | -76,368 | -72,967 |
EBIT | -139,424 | -104,177 | -84,578 | -81,208 |
Net Income | -148,701 | -110,776 | -11,965 | -26,477 |
Net Change In Cash | 0 | 0 | 1,565 | 1,263 |
Cost of Revenue | -67,730 | 177,573 | ||
Free Cash Flow | -99,694 | -75,585 | -72,177 | -81,410 |
Cash | 44,937 | 80,448 | 149,772 | 217,502 |
Basic Shares | 118,479 | 103,420 | 103,051 | 39,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.14 |
2025-06-30 | -$0.24 |
2025-03-31 | -$0.08 |
2024-12-31 | -$0.20 |
